Moolec Has Received USDA Approval for the First Genetically Modified Pea in History
Moolec Science SA (NASDAQ:MLEC) has received USDA approval for the first genetically modified pea in history. The U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) completed its Regulatory Status Review for Moolec's genetically engineered peas that produce iron through bovine meat proteins. This marks Moolec's third USDA-APHIS regulatory clearance in 18 months, following approvals for genetically engineered safflower and soybean.
The GE peas produce high yields of bovine myoglobin, boosting iron content and offering a plant-based iron source. This innovation has the potential to impact both the food ingredient market and the $65 billion pea industry. The approval validates Moolec's strategic approach and commitment to sustainable food production through science and innovation.
Moolec Science SA (NASDAQ:MLEC) ha ricevuto l'approvazione del USDA per il primo pisello geneticamente modificato della storia. Il Servizio per l'Ispezione della Salute Animale e Vegetale (APHIS) del Dipartimento dell'Agricoltura degli Stati Uniti ha completato la sua Revisione dello Stato Normativo per i piselli geneticamente modificati di Moolec, che producono ferro attraverso le proteine della carne bovina. Questo segna la terza autorizzazione normativa USDA-APHIS di Moolec in 18 mesi, dopo le approvazioni per il girasole e la soia geneticamente modificati.
I piselli GE producono alti rendimenti di mioglobina bovina, aumentando il contenuto di ferro e offrendo una fonte di ferro vegetale. Questa innovazione ha il potenziale di influenzare sia il mercato degli ingredienti alimentari sia l'industria dei piselli da 65 miliardi di dollari. L'approvazione convalida l'approccio strategico di Moolec e il suo impegno per la produzione alimentare sostenibile attraverso la scienza e l'innovazione.
Moolec Science SA (NASDAQ:MLEC) ha recibido la aprobación del USDA para el primer guisante genéticamente modificado en la historia. El Servicio de Inspección de Salud Animal y Vegetal (APHIS) del Departamento de Agricultura de EE.UU. completó su Revisión del Estado Regulatorio para los guisantes modificados genéticamente de Moolec, que producen hierro a través de proteínas de carne bovina. Este hecho marca la tercera autorización regulatoria de Moolec por parte del USDA-APHIS en 18 meses, tras las aprobaciones para el girasol y la soya modificados genéticamente.
Los guisantes GE producen altos rendimientos de mioglobina bovina, aumentando el contenido de hierro y ofreciendo una fuente de hierro a base de plantas. Esta innovación tiene el potencial de impactar tanto el mercado de ingredientes alimentarios como la industria de los guisantes de 65 mil millones de dólares. La aprobación valida el enfoque estratégico de Moolec y su compromiso con la producción de alimentos sostenibles a través de la ciencia y la innovación.
무홀릭 사이언스 SA (NASDAQ:MLEC)는 역사상 첫 유전자 변형 완두콩에 대한 USDA 승인을 받았습니다. 미국 농무부의 동물 및 식물 건강 검사 서비스(APHIS)는 무홀릭의 유전자 수식 완두콩이 소고기 단백질을 통해 철분을 생성하는 것에 대한 규제 상태 검토를 완료했습니다. 이는 무홀릭의 18개월 동안 세 번째 USDA-APHIS 규제 승인으로, 이전에 유전자 변형으로 개발된 해바라기 및 대두에 대한 승인과 이어집니다.
GE 완두콩은 높은 수량의 소 마이오글로빈을 생산하여 철분 함량을 높이고 식물 기반의 철분 공급원을 제공합니다. 이 혁신은 식품 성분 시장과 650억 달러 규모의 완두콩 산업에 영향을 미칠 잠재력이 있습니다. 이 승인은 무홀릭의 전략적 접근 방식과 과학 및 혁신을 통한 지속 가능한 식품 생산에 대한 헌신을 검증합니다.
Moolec Science SA (NASDAQ:MLEC) a reçu l'approbation de l'USDA pour le premier pois génétiquement modifié de l'histoire. Le Service de l'inspection de la santé animale et végétale (APHIS) du Département de l'Agriculture des États-Unis a terminé sa révision du statut réglementaire pour les pois génétiquement modifiés de Moolec, qui produisent du fer à partir de protéines de viande bovine. Cela marque la troisième approbation réglementaire de Moolec par l'USDA-APHIS en 18 mois, après les approbations pour le tournesol et le soja génétiquement modifiés.
Les pois GE produisent de forts rendements de myoglobine bovine, augmentant la teneur en fer et offrant une source de fer d'origine végétale. Cette innovation a le potentiel d'impacter à la fois le marché des ingrédients alimentaires et l'industrie des pois de 65 milliards de dollars. L'approbation valide l'approche stratégique de Moolec et son engagement envers une production alimentaire durable grâce à la science et à l'innovation.
Moolec Science SA (NASDAQ:MLEC) hat die Genehmigung des USDA für die erste genetisch veränderte Erbse in der Geschichte erhalten. Der Animal and Plant Health Inspection Service (APHIS) des US-Landwirtschaftsministeriums hat seine Überprüfung des regulatorischen Status für die genetisch veränderten Erbsen von Moolec abgeschlossen, die Eisen über Rindfleischproteine produzieren. Dies markiert die dritte regulatorische Zulassung von Moolec durch das USDA-APHIS in 18 Monaten, nach Genehmigungen für genetisch veränderte Sonnenblumen und Sojabohnen.
Die GE-Erbsen produzieren hohe Erträge an Myoglobin aus Rindfleisch, was den Eisengehalt erhöht und eine pflanzliche Eisenquelle bietet. Diese Innovation hat das Potenzial, sowohl den Markt für Zutaten als auch die 65-Milliarden-Dollar-Erbsenindustrie zu beeinflussen. Die Genehmigung validiert Moolecs strategischen Ansatz und Engagement für nachhaltige Lebensmittelproduktion durch Wissenschaft und Innovation.
- Received USDA approval for the first genetically modified pea in history
- Third USDA-APHIS regulatory clearance in 18 months
- Potential to impact the $65 billion pea industry
- GE peas produce high yields of bovine myoglobin, offering a plant-based iron source
- Positioned to lead innovation in food and agriculture sectors
- None.
Insights
This USDA approval for Moolec's genetically engineered pea is a significant milestone in agricultural biotechnology. It's the first-ever approval for a GE pea, demonstrating Moolec's innovative approach in Molecular Farming. The pea, engineered to produce bovine myoglobin, addresses the growing demand for plant-based iron sources.
The approval's implications are far-reaching:
- It opens doors for expanded field trials and eventual commercialization
- Potentially revolutionizes the
$65 billion pea industry - Offers a new, nutritious alternative in the food ingredient market
Moolec's achievement of three USDA approvals in 18 months for different crops (safflower, soybean and now pea) showcases their leadership in the Molecular Farming space. This rapid regulatory progress, coupled with their existing commercial contract, positions Moolec as a frontrunner in bringing GE crops to market.
Moolec's GE pea represents a significant advancement in functional foods. By incorporating bovine myoglobin into peas, they've created a plant-based product with enhanced iron content, addressing a common nutritional gap in vegetarian and vegan diets.
Key nutritional implications:
- Increased bioavailable iron in a plant-based format
- Potential to reduce iron deficiency, a global health concern
- May improve the nutritional profile of plant-based meat alternatives
This innovation aligns with the growing consumer demand for nutritious, sustainable food options. It bridges the gap between plant-based diets and essential nutrient intake, particularly iron, which is important for various bodily functions. The product's potential to revolutionize both the food ingredient market and the pea industry suggests a significant impact on future food formulations and consumer choices.
LUXEMBOURG / ACCESSWIRE / October 16, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE") peas which produce iron through bovine meat proteins. This is the third regulatory clearance from USDA-APHIS achieved by Moolec in an 18-month window, alongside its genetically engineered safflower and soybean for GLASO™ and Piggy Sooy™ products, respectively. Access the official USDA-APHIS publication here.
"With USDA approval for our GE pea, Moolec has now secured regulatory clearance for all of our key crops in the US: safflower, soybean, and pea," said Gastón Paladini, CEO and Co-Founder of Moolec. "We are proud to be the only Molecular Farming company with three US regulatory approvals and a major commercial contract. This milestone underscores our leadership in the landscape with tangible, science-backed results."
Moolec's genetically engineered peas produce high yields of bovine myoglobin, a protein that boosts iron content, making it an ideal alternative for consumers seeking plant-based sources of iron. This product has the potential to revolutionize both the food ingredient market and the
Amit Dhingra, Chief Science Officer for the Company, stated, "The USDA-APHIS Regulatory Status Review for pea marks a significant milestone for Moolec. As the first review for GE pea, it represents a historic development. It validates Moolec's strategic approach and exemplifies our commitment advancing sustainable food production through science and innovation. This approval is a critical step toward enhancing global food supply and meeting the growing demand for innovative, nutritious food solutions for the world."
This approval not only showcases Moolec's innovation in Molecular Farming but also highlights the company's commitment to meeting the highest regulatory and safety standards. Moolec has also developed an Identity Preservation Program to ensure sustainable farming practices, promote stewardship for its crops and product quality for partners, clients and consumers alike.
According to USDA-APHIS regulation found at 7 CFR part 340, developers may submit a request for a RSR when they believe a GE plant is not subject to the regulation. APHIS reviews the GE plant and considers whether it might pose an increased plant pest risk compared to its non-GE comparator. If APHIS does not identify a greater pest risk relative to the comparator, the GE plant is not subject to this regulation. Regulation 7 CFR part 340 governs the importation, interstate movement, and the environmental release of certain organisms that have been modified or produced by genetic engineering.
The USDA-APHIS review process is a critical component of ensuring that genetically engineered crops can be grown safely, and this approval opens the floor for expanded field trials, seed scaling, and eventual commercialization. With increasing interest in science-based ingredients, this approval positions the company to lead a new wave of innovation in the food and agriculture sectors.
About Moolec Science SA
Moolec is a science-based ingredient company leader in the use of Molecular Farming technology for food and dietary supplementation markets. The Company's mission is to create unique food ingredients by engineering plants with animal protein genes. Its purpose is to redefine the way the world produces animal proteins for the good of the planet. Moolec's technological approach aims to have the cost structure of plant-based solutions with the nutrition and functionality of animal-based ones. Moolec's technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The Company's product portfolio and pipeline leverage the agronomic efficiency of broadly used target crops like soybean, pea, and safflower to produce oils and proteins. Moolec also has an industrial and commercial R&D capability to complement the company's Molecular Farming technology. Moolec secures a growing international patent portfolio (25+, both granted and pending) for its Molecular Farming technology. The Company is run by a diverse team of PhDs and Food Insiders, and operates in the United States, Europe, and South America. For more information, visit moolecscience.com and ir.moolecscience.com.
Forward-Looking Statements
This publication contains "forward-looking statements." Forward-looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements with respect to performance, prospects, revenues, and other aspects of the business of Moolec are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Although we believe that we have a reasonable basis for each forward-looking statement contained in this publication, we caution you that these statements are based on a combination of facts and factors, about which we cannot be certain. We cannot assure you that the forward-looking statements in this publication will prove accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among others, changes in applicable laws or regulations, the possibility that Moolec may be adversely affected by economic, business and/or other competitive factors, costs related to the scaling up of Moolec's business and other risks and uncertainties, including those included under the header "Risk Factors" in Moolec's Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission ("SEC"), as well as Moolec's other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, you should not put undue reliance on these statements.
Contact Information
Press & Media
comms@moolecscience.com
Investor Relations
ir@moolecscience.com
Related Files
Moolec Has Received USDA Approval For The First Genetically Modified Pea In History
SOURCE: Moolec Science
View the original press release on newswire.com.
FAQ
What is the significance of Moolec's USDA approval for genetically engineered peas?
How many USDA-APHIS regulatory clearances has Moolec (MLEC) received in the past 18 months?
What potential impact could Moolec's genetically engineered peas have on the pea industry?
What protein do Moolec's genetically engineered peas produce?
